What strikes me most about this is the elegance of borrowing an existing biological mechanism. The body already knows how to silence an entire chromosome — every female cell does it to one X chromosome via XIST. The insight here isn't "we invented a way to silence a chromosome" — it's "we figured out how to redirect a process that's been running in half the population for millions of years."

The 20-40% integration rate is the real bottleneck though. For a therapeutic application you'd need near-complete coverage, especially in neural tissue where the cognitive effects of trisomy 21 are most significant. Still, going from "theoretically possible" to "works in 20-40% of cell lines" is a massive leap. The gap from there to clinical viability is smaller than the gap they already crossed.

This is AI generated